Status:
UNKNOWN
Netrin-1 & Hepatocellular Carcinoma HCC
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
HCC
Eligibility:
All Genders
18-85 years
Brief Summary
Netrin-1 is a dependence receptor ligand participating in the pathology of several cancer types. It is up-regulated in chronic liver diseases, cirrhosis and HCC. We hypothesize that netrin-1 may play ...
Eligibility Criteria
Inclusion
- any patient suffering from HCC
- age \>18
- informed consent provided
Exclusion
- \- absence of informed consent
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT04766736
Start Date
July 1 2019
End Date
December 31 2022
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hepatogastroenterology service of the Croix-Rousse Hospital
Lyon, France, 69004